Work

Abstract PS2-06: First-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs combination chemotherapy (combo CT) in clinically aggressive HR+/HER2- advanced breast cancer (ABC): a subgroup analysis of RIGHT Choice by intrinsic subtype & gene & signature expression

Year: 2025

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs24-ps2-06

Authors: Yen-Shen Lu, Chia-Lang Hsu, Eznal Izwadi Bin Mohd Mahidin, Sudeep Gupta, Erhan Gökmen, Elena Artamonova, Huang-Chun Lien, Hamdy Azim, Yoon-Sim Yap, Yesim Eralp, Seock-Ah Im, Fei Su, Yogesh Chattar, Estelle Roux, Melissa Gao, Nagi S. El Saghir

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4411286275

Cites:

Cited by: 1

Related to: 10